SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
100 hedge funds and large institutions have $276M invested in Syros Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 20 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
66% less call options, than puts
Call options by funds: $893K | Put options by funds: $2.66M
Holders
100
Holding in Top 10
1
Calls
$893K
Puts
$2.66M
Top Buyers
| 1 | +$5.18M | |
| 2 | +$4.64M | |
| 3 | +$4.36M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
+$3.88M |
| 5 |
AG
Artal Group
Luxembourg
|
+$3.68M |
Top Sellers
| 1 | -$57.7M | |
| 2 | -$38.6M | |
| 3 | -$37.7M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$3.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.36M |